• MTT as a Strategic Linchpin in Translational Research: Me...

  2025-10-22

  Discover how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) bridges fundamental mechanistic understanding with strategic guidance for translational researchers. This thought-leadership article explores the biological rationale for tetrazolium-based cell viability assays, contextualizes recent neurodegenerative disease findings, and provides a roadmap for leveraging MTT to unlock deeper insights in experimental and clinical research.

• Doxorubicin in Next-Generation Cancer Models: Mechanisms,...

  2025-10-21

  Explore the advanced role of Doxorubicin, a leading DNA topoisomerase II inhibitor, in cancer research using iPSC-derived models and AI-driven toxicity screening. This article uniquely integrates mechanistic detail, high-throughput experimental design, and future-ready phenotypic analysis.

242 records 17/17 page Previous First page 上5页 1617